Endorsed resource - decision support tool

A joint working group initiative comprising the National Institute for Health and Care Excellence (NICE), Boehringer Ingelheim Ltd and Prescribing Decision Support Ltd at the Centre for Medicines Optimisation, Keele University have produced a decision support tool that supports the majority of recommendations relating to the diagnosis and assessment of atrial fibrillation, assessment of stroke and bleeding risks and anticoagulation in the NICE guideline on atrial fibrillation. It supports the NICE technology appraisal on edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation. It also supports the contents in the NICE patient decision aid for atrial fibrillation.

This tool is for use with adults (aged 18 years and over) who have suspected or diagnosed non-valvular atrial fibrillation.

This tool should not be used by persons other than UK healthcare professionals in the appropriate prescribing of anticoagulation therapy for the prevention of stroke in patients with atrial fibrillation.

Endorsed tools are complementary information that may be of interest to you from sources outside of NICE. This tool has been hosted by Keele University and is not maintained by NICE. NICE has not made any judgement about the quality and usability of the resource. In the event of any issues or errors, please contact anticoagulation_therapy@pds-keele.co.uk in the first instance.


This page was last updated: 29 July 2016